Recently, DNAJB6 was shown to also interact with the highly aggregation-prone amyloid-beta Aβ42 peptide (involved in Alzheimer disease) and efficiently inhibit amyloid aggregation (Mansson et al., 2014). Here, DNAJB6 is linked to early-onset autosomal dominant Alzheimer disease.